Related Experiment Video

Updated: Jun 30, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Survival from multiple myeloma in England and Wales up to 2001

S Schey1

  • 1Department of Haematology, King's College Hospital, Denmark Hill, London SE5 9RS, UK. steve.schey@kch.nhs.uk

British Journal of Cancer
|October 1, 2008
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Related Experiment Videos

Last Updated: Jun 30, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

Articles linked to this work by shared authors, journal, and citation graph.

Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option.

Bone marrow transplantation·2022

Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma.

Annals of hematology·2010

United Kingdom myeloma forum position statement on the use of lenalidomide in multiple myeloma.

International journal of laboratory hematology·2008

The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.

Bone marrow transplantation·2007

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia.

The European respiratory journal·2004

Inflammatory biomarkers and risk of postmenopausal oestrogen receptor-positive breast cancer: a case-cohort analysis.

British journal of cancer·2026

PAX9 activates autophagy through a transcription-dependent mechanism, promoting EGFR degradation to restrict cell survival in oral cancer.

British journal of cancer·2026

TSPAN32 enhances CAR-T cell potency by assembling IL-2 receptor complex and amplifying its intracellular signal transduction.

British journal of cancer·2026

Genomic and transcriptomic landscape of spread through air spaces in stage 1 lung adenocarcinoma.

British journal of cancer·2026

Early-adulthood body mass index, mammographic density and post-menopausal breast cancer risk: a mediation analysis.

British journal of cancer·2026

Menopausal hormone therapy and primary liver cancer: long-term follow-up of the women's health initiative randomized trials.

British journal of cancer·2026

[Evaluation of Habitat Quality and Driving Forces Analysis in the Qarqan River Basin Based on an Enhanced Remote Sensing Ecological Index].

Huan jing ke xue= Huanjing kexue·2026

Negotiating Wetlands: Convivial Conservation and Collective Wetland Management in Ada, Ghana.

Environmental management·2026

Quantifying the Evolutionary Potential for Delta Smelt Persistence in a Warming Habitat.

Evolutionary applications·2026

Contrasting carbon and nitrogen burial in pristine vs. impacted mangrove sediments.

Marine pollution bulletin·2026

[Land Use Change and Biodiversity Change in Shaanxi Province Under Multi-scenario Simulation].

Huan jing ke xue= Huanjing kexue·2026

Heavy metal exposure and ecological risk assessment in the Guizhou snub-nosed monkey (Rhinopithecus brelichi): a fecal biomonitoring study.

Frontiers in veterinary science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us